Market Research Topics
View Topics Beginning with:
A B C D E F G H I J K L M N O P Q R S T U T V W X Y Z
About SPi Reports
The SPi-Reports.com website specialises in selling a wide spectrum of market research and company reports from leading market research publishers.
UK Based
We are based in the UK and are committed to quality customer service. If you need help, contact our sales team for personal assistance: phone +44 (0) 1305 753769 or email office@sectorpublishing.com.
Sector Publishing Intelligence [SPi] Network
At SPi we publish several large sector-specific news websites that aim to increase the sophistication of press/news dissemination on the web.
This comprehensive overview of all sectors of the economy gives us a clear insight into the issues and trends in different markets.
It also makes us the go-to website for researchers and publishers of market data to find and publish their market intelligence information.
Mitsubishi Tanabe Pharma Corporation - Strategy and SWOT Report
Report Summary
Published by Marketline: 20 Feb 2012
Buy This Report Now |
Ordering InformationOrders are processed immediately and you will be notified of the despatch date on confirmation of your order. Accepted Card TypesBuy now using our secure payment system. |
Mitsubishi Tanabe Pharma Corporation - SWOT Analysis company profile is the essential source for top-level company data and information. Mitsubishi Tanabe Pharma Corporation - SWOT Analysis examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Mitsubishi Tanabe Pharma (Mitsubishi Tanabe) is engaged in the development, manufacturing, marketing, export and import of ethical drugs, over-the-counter (OTC) drugs and diagnostic agents. The company operates in Japan with some operations in foreign countries. It is headquartered in Osaka and employed 9,198 people as of March 31, 2011. The company recorded revenues of JPY409,540 million (approximately ,791.6 million) during the financial year ended March 2011 (FY2011), an increase of 1.2% over FY2010. The operating profit of the company was JPY76,584 million (approximately 6 million) during FY2011, an increase of 24.6% over FY2010. The net profit was JPY37,747 million (approximately 1.6 million) in FY2011, an increase of 24.8% over FY2010.
Scope of the Report
- Provides all the crucial information on Mitsubishi Tanabe Pharma Corporation required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting Mitsubishi Tanabe Pharma Corporation in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of Mitsubishi Tanabe Pharma Corporation
-Data is supplemented with details on Mitsubishi Tanabe Pharma Corporation history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from Mitsubishi Tanabe Pharma Corporation
Reasons to Purchase
- Support sales activities by understanding your customers’ businesses better
- Understand prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available
Buy This Report Now |
Ordering InformationOrders are processed immediately and you will be notified of the despatch date on confirmation of your order. Accepted Card TypesBuy now using our secure payment system. |
This report is published by Marketline
MarketLine is a global publisher of company, industry and country information. Their clients operate across a wide variety of industries and job functions and range from multinational corporations right down to small businesses in both developed and developing economies.MarketLine users enjoy access to content that is trustworthy, up to date and reasonably priced and routinely turn to us as their first-stop resource for instantly accessible, reliable business information.
Brochures